BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1724967)

  • 1. Spinal cord substance P mediates the inhibition of gastric acid secretion induced by electrical stimulation of the preoptic area.
    Okuma Y; Osumi Y
    Eur J Pharmacol; 1991 Sep; 202(2):227-33. PubMed ID: 1724967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual effects on gastric acid secretion of electrical stimulation of anterior parts of the rat hypothalamus.
    Okuma Y; Osumi Y
    Jpn J Pharmacol; 1989 Jan; 49(1):37-42. PubMed ID: 2724681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant interleukin-1 beta inhibits gastric acid secretion by activation of central sympatho-adrenomedullary outflow in rats.
    Yokotani K; Okuma Y; Osumi Y
    Eur J Pharmacol; 1995 Jun; 279(2-3):233-9. PubMed ID: 7556406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of substance P on cholinergically stimulated gastric acid secretion and mucosal blood flow in rats.
    Yokotani K; Fujiwara M
    J Pharmacol Exp Ther; 1985 Mar; 232(3):826-30. PubMed ID: 2579233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympatho-adrenomedullary system mediation of the bombesin-induced central inhibition of gastric acid secretion.
    Okuma Y; Yokotani K; Osumi Y
    Eur J Pharmacol; 1987 Jul; 139(1):73-8. PubMed ID: 3115795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central site of inhibitory action of bombesin on gastric acid secretion in rats.
    Okuma Y; Yokotani K; Osumi Y
    Jpn J Pharmacol; 1987 Oct; 45(2):129-33. PubMed ID: 3437584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracerebroventricularly administered nicotine inhibits vagally stimulated gastric acid output in rats by activating the central sympatho-adrenal outflow.
    Yokotani K; Okuma Y; Osumi Y
    Jpn J Pharmacol; 1987 Oct; 45(2):288-91. PubMed ID: 3437596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of naloxone on vagally-induced gastric acid secretion in rats.
    Stapelfeldt W; Schusdziarra V; Allescher HD; Weigert N; Classen M
    Neuropeptides; 1988 Jul; 12(1):13-20. PubMed ID: 3419556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal administration of a substance P receptor antagonist: studies on peripheral and central nervous system hemodynamics and on specificity of action.
    Helke CJ; Phillips ET; O'Neill JT
    J Pharmacol Exp Ther; 1987 Jul; 242(1):131-6. PubMed ID: 2441024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of spinal cord substance P: studies with a stable receptor agonist.
    Keeler JR; Charlton CG; Helke CJ
    J Pharmacol Exp Ther; 1985 Jun; 233(3):755-60. PubMed ID: 2409270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of vagally mediated gastric acid secretion by activation of central prostanoid EP3 receptors in urethane-anaesthetized rats.
    Yokotani K; Okuma Y; Osumi Y
    Br J Pharmacol; 1996 Feb; 117(4):653-6. PubMed ID: 8646410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuropharmacological studies on the sympathetic inhibitory mechanisms of gastric acid secretion].
    Yokotani K
    Nihon Yakurigaku Zasshi; 1987 Nov; 90(5):259-66. PubMed ID: 2832282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cardiovascular sympathetic neurons by substance P and gamma-aminobutyric acid in the rat spinal cord.
    Hasséssian H; Prat A; De Champlain J; Couture R
    Eur J Pharmacol; 1991 Sep; 202(1):51-60. PubMed ID: 1723952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathoadrenomedullary system mediation of the prostaglandin E2-induced central inhibition of gastric acid output in rats.
    Yokotani K; Yokotani K; Okuma Y; Osumi Y
    J Pharmacol Exp Ther; 1988 Jan; 244(1):335-40. PubMed ID: 3422095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine applied into the dorsal motor nucleus of the vagus inhibits enhanced gastric acid output and mucosal blood flow in rats.
    Nagata M; Okuma Y; Osumi Y
    Eur J Pharmacol; 1986 Mar; 121(3):313-8. PubMed ID: 3699099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive modulation of pepsinogen secretion by gastric acidity after vagal cholinergic stimulation.
    Blandizzi C; Colucci R; Carignani D; Lazzeri G; Del Tacca M
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1043-50. PubMed ID: 9399975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capsaicin-sensitive vagal stimulation-induced gastric acid secretion in the rat: evidence for cholinergic vagal afferents.
    Sharkey KA; Oland LD; Kirk DR; Davison JS
    Br J Pharmacol; 1991 Aug; 103(4):1997-2003. PubMed ID: 1680518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the vascular permeability induced by intrathecal substance P and bradykinin in the rat.
    Jacques L; Couture R
    Eur J Pharmacol; 1990 Aug; 184(1):9-20. PubMed ID: 1698644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the cardiovascular effects produced by the spinal action of substance P in the rat.
    Couture R; Hasséssian H; Gupta A
    J Cardiovasc Pharmacol; 1988 Mar; 11(3):270-83. PubMed ID: 2452919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the role of substance P and serotonin in the pyloric motor control. An experimental study in cat and rat.
    Lidberg P
    Acta Physiol Scand Suppl; 1985; 538():1-69. PubMed ID: 2418634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.